Fineline Cube

Follow:
14433 Articles
Abbisko's ABSK043 Gains IND Approval for KRAS G12C NSCLC in Partnership with Allist
CompanyDeals

Abbisko’s ABSK043 Gains IND Approval for KRAS G12C NSCLC in Partnership with Allist

Sino Biopharma's Zongertinib Receives Second Breakthrough Designation for NSCLC
CompanyDrug

Sino Biopharma’s Zongertinib Receives Second Breakthrough Designation for NSCLC

Haohai Biotech Terminates OK Lens Distribution Deal with Brighten Optix Amid Carl Zeiss Acquisition
CompanyDeals

Haohai Biotech Terminates OK Lens Distribution Deal with Brighten Optix Amid Carl Zeiss Acquisition

Nanjing Zenshine Pharma Partners with Cigalah Medpharm to Advance Sebaloxavir Marboxil in MENA
CompanyDeals

Nanjing Zenshine Pharma Partners with Cigalah Medpharm to Advance Sebaloxavir Marboxil in MENA

China Releases Draft Guidelines for Single-Arm Oncology Trials to Support Drug Approvals
Policy / Regulatory

China Releases Draft Guidelines for Single-Arm Oncology Trials to Support Drug Approvals

Ascentage Pharma Reports H1 2025 Financial Results, Shows Strong Growth in Olverembatinib Sales
Company

Ascentage Pharma Reports H1 2025 Financial Results, Shows Strong Growth in Olverembatinib Sales

Chongqing Genrix Bio Pharmaceutical's GR1802 Injection Receives NMPA Approval for Seasonal Allergic Rhinitis in Adolescents
CompanyDrug

Chongqing Genrix Bio Pharmaceutical’s GR1802 Injection Receives NMPA Approval for Seasonal Allergic Rhinitis in Adolescents

Santhera Pharmaceuticals Signs Exclusive Agreement with Uniphar for AGAMREE Distribution in Middle East
CompanyDeals

Santhera Pharmaceuticals Signs Exclusive Agreement with Uniphar for AGAMREE Distribution in Middle East

Vivatides Therapeutics Completes Multi-Million Dollar Seed Financing to Advance Nucleic Acid Delivery Platform
CompanyDeals

Vivatides Therapeutics Completes Multi-Million Dollar Seed Financing to Advance Nucleic Acid Delivery Platform

China Unveils Ten Measures to Boost Family Doctor Contract Services
Policy / Regulatory

China Unveils Ten Measures to Boost Family Doctor Contract Services

Hunan FangSheng Pharmaceutical to Acquire JAK Inhibitor Patent Rights for RMB 80 Million
CompanyDeals

Hunan FangSheng Pharmaceutical to Acquire JAK Inhibitor Patent Rights for RMB 80 Million

Haihe Biopharma Seeks Japan Approval for Risovalisib in PIK3CA-Mutated Ovarian Cancer
CompanyDrug

Haihe Biopharma Seeks Japan Approval for Risovalisib in PIK3CA-Mutated Ovarian Cancer